Asiatic Laboratories Limited (DSE:ASIATICLAB)
106.00
-4.80 (-4.33%)
At close: May 6, 2026
Asiatic Laboratories Market Cap
Asiatic Laboratories has a market cap or net worth of 13.56 billion as of May 6, 2026. Its market cap has increased by 210.36% in one year.
Market Cap
13.56B
Enterprise Value
15.02B
Revenue
2.24B
Ranking
n/a
PE Ratio
35.87
Stock Price
106.00
Market Cap Chart
Since March 6, 2024, Asiatic Laboratories's market cap has increased from 2.69B to 13.56B, an increase of 403.64%. That is a compound annual growth rate of 111.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 13.56B | 133.26% |
| Dec 30, 2025 | 5.81B | 31.94% |
| Dec 30, 2024 | 4.41B | 63.64% |
| Mar 6, 2024 | 2.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 52.20B |
| Renata | 47.51B |
| Unilever Consumer Care | 39.89B |
| Beacon Pharmaceuticals | 23.70B |
| The ACME Laboratories | 16.04B |
| The IBN SINA Pharmaceutical Industry | 9.62B |
| Navana Pharmaceuticals | 6.35B |
| Orion Pharma | 6.13B |